PFE - Moderna Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits | Benzinga
The U.S. Food and Drug Administration on Monday approved and authorized updated COVID-19 vaccines by Moderna Inc (NASDAQ: MRNA) and partners Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX)
aimed at better countering circulating viral strains, including the omicron variant XBB.1.5.
The FDA said it is confident in the updated vaccines' safety and efficac. The vaccines are expected to effectively guard against current COVID-19 strains.
Both Pfizer and Moderna confirmed the updated vaccines will be ready by the fall, with the FDA ...